Terms: = Liver cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864
161 results:
1. Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against liver cancer.
Chen S; Li M; Xue C; Zhou X; Wei J; Zheng L; Duan Y; Deng H; Tang F; Xiong W; Xiang B; Zhou M
Drug Des Devel Ther; 2024; 18():1321-1338. PubMed ID: 38681206
[TBL] [Abstract] [Full Text] [Related]
2. [Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
Sang D; Fan SM; Li SY; Zhang JT; Wang HM; Zhao XH; Zheng LJ; Liang P; Xi GB; Zhao LM; Zhang YR; Yuan P
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):256-262. PubMed ID: 38494772
[No Abstract] [Full Text] [Related]
3. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
[TBL] [Abstract] [Full Text] [Related]
4. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of integrated hepatitis B virus DNA harboring pre-S mutations in hepatocellular carcinoma patients with ground glass hepatocytes.
Su YP; Lin SY; Su IJ; Kao YL; Shen SC; Earl JP; Ehrlich GD; Chen CY; Huang W; Su YH; Tsai HW
J Med Virol; 2024 Jan; 96(1):e29348. PubMed ID: 38180275
[TBL] [Abstract] [Full Text] [Related]
6. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States.
Guo Y; Shen B; Xue Y; Li Y
Front Endocrinol (Lausanne); 2023; 14():1207365. PubMed ID: 37732127
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of local tumor progression after microwave ablation for early-stage hepatocellular carcinoma with machine learning.
Ren H; An C; Fu W; Wu J; Yao W; Yu J; Liang P
J Cancer Res Ther; 2023 Aug; 19(4):978-987. PubMed ID: 37675726
[TBL] [Abstract] [Full Text] [Related]
9. Postoperative Prognosis of Non-alcoholic Fatty liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.
Yu Q; Lei Z; Ma W; Yang F; Tang H; Xiao Q; Tang X; Si A; Yang P; Zhou N; Cheng Z
J Gastrointest Surg; 2023 Nov; 27(11):2403-2413. PubMed ID: 37582919
[TBL] [Abstract] [Full Text] [Related]
10. Laparoscopic Anatomical liver Resection of Segment VIII by Using ICG Fluorescence Positive Staining Under the Guidance of Laparoscopic Ultrasonography.
Sun J; Lu ZY; Zhai JX; Lang MR; Wang HG
Ann Surg Oncol; 2023 Nov; 30(12):7358-7359. PubMed ID: 37556011
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
[TBL] [Abstract] [Full Text] [Related]
12. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract] [Full Text] [Related]
13. Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited liver Resections of the Posterosuperior Segments: An International Multicenter Study.
Krenzien F; Schmelzle M; Pratschke J; Feldbrügge L; Liu R; Liu Q; Zhang W; Zhao JJ; Tan HL; Cipriani F; Hoogteijling TJ; Aghayan DL; Fretland ÅA; Siow TF; Lim C; Scatton O; Herman P; Coelho FF; Marino MV; Mazzaferro V; Chiow AKH; Sucandy I; Ivanecz A; Choi SH; Lee JH; Gastaca M; Vivarelli M; Giuliante F; Dalla Valle B; Ruzzenente A; Yong CC; Chen Z; Yin M; Fondevila C; Efanov M; Morise Z; Di Benedetto F; Brustia R; Dalla Valle R; Boggi U; Geller D; Belli A; Memeo R; Gruttadauria S; Mejia A; Park JO; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Hasegawa K; Tang CN; Chong CCN; Lee KF; Meurs J; D'Hondt M; Monden K; Lopez-Ben S; Kingham TP; Ferrero A; Ettorre GM; Pascual F; Cherqui D; Zheng J; Liang X; Soubrane O; Wakabayashi G; Troisi RI; Cheung TT; Kato Y; Sugioka A; Dokmak S; D'Silva M; Han HS; Nghia PP; Long TCD; Hilal MA; Chen KH; Fuks D; Aldrighetti L; Edwin B; Goh BKP;
Ann Surg; 2024 Feb; 279(2):297-305. PubMed ID: 37485989
[TBL] [Abstract] [Full Text] [Related]
14. The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value.
Sheng R; Yang C; Zhang Y; Wang H; Zheng B; Han J; Sun W; Zeng M
Radiol Med; 2023 Sep; 128(9):1047-1060. PubMed ID: 37474663
[TBL] [Abstract] [Full Text] [Related]
15. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
Yu X; Yang R; He Z; Li K; Zeng P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
[TBL] [Abstract] [Full Text] [Related]
16. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract] [Full Text] [Related]
17. H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3.
Li G; Wang B; Li L; Li X; Yan R; Liang J; Zhou X; Li L; Zhou Z
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903516
[TBL] [Abstract] [Full Text] [Related]
18. Examining the effect of
Ahmadzadeh A; Rashidi M; Mohsenifar Z; Faeghi F; Rezaei-Tavirani M; Ahmadi N; Zali MR; Alebouyeh M; Feizi M; Ahmadzadeh Z
Horm Mol Biol Clin Investig; 2023 Sep; 44(3):251-258. PubMed ID: 36872607
[TBL] [Abstract] [Full Text] [Related]
19. Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years.
Forni GL; Gianesin B; Musallam KM; Longo F; Rosso R; Lisi R; Gamberini MR; Pinto VM; Graziadei G; Vitucci A; Bonetti F; Musto P; Piga A; Cappellini MD; Borgna-Pignatti C;
Am J Hematol; 2023 Mar; 98(3):381-387. PubMed ID: 36588408
[TBL] [Abstract] [Full Text] [Related]
20. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss.
Yip TC; Wong VW; Lai MS; Lai JC; Hui VW; Liang LY; Tse YK; Chan HL; Wong GL
J Hepatol; 2023 Mar; 78(3):524-533. PubMed ID: 36463985
[TBL] [Abstract] [Full Text] [Related]
[Next]
